EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome

Alma Nurtazina iD, Valeriia Koss, Ivan Voitsekhovskiy, Maxat Toishimanov iD, Daulet Dautov, Kairat Karibayev, Victoria Shender iD, Georgij Arapidi iD

Journal of Personalized Medicine · 11.08.2026 · 16 (8) · 425

DOI: 10.3390/jpm16080425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 11.08.2026. Verfasst von Alma Nurtazina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Semey Medical University, 071400 Semey, Kazakhstan. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic syndrome (MetS) is a heterogeneous cardiometabolic group of conditions in which early disturbances of glucose homeostasis are not always adequately captured by routine clinical tests.

Methods

In this pilot study, liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based blood serum peptidomics was applied to identify circulating peptide signatures associated with MetS and progressive glycemic impairment. Serum samples from healthy donors and patients with MetS, including subgroups with normoglycemia, prediabetes, and diabetes mellitus, were subjected to peptide enrichment by ultrafiltration and solid-phase extraction prior to LC-MS/MS analysis.

Results

Overall, 6754 unique peptides derived from 1820 precursor proteins were identified, and 32 peptides were significantly overrepresented in patients with MetS relative to healthy donors. Eight precursor proteins and five identified peptides showed significant positive correlations with glycemic stage, likely indicating progressive remodeling of the circulating serum peptidome during disease progression. A separate analysis of patients with prediabetes revealed additional candidate markers associated with early metabolic alterations. Moreover, multivariate logistic regression identified a four-peptide panel with good discriminatory performance for differentiating healthy donors from patients with MetS, yielding a leave-one-out cross-validated area under the curve of 0.91.

Conclusions

Collectively, these findings indicate that serum peptidome profiling can reveal biologically and clinically relevant possible candidate biomarkers associated with MetS and early dysglycemia.

Schlagwörter

Stichwörter der Autor:innen

LC-MS/MSblood serum peptidomicsdiabetes mellitusmetabolic syndromepeptide biomarkersprediabetes

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Semey Medical University, 071400 Semey, Kazakhstan.
  • Outpatient Clinic #1, Department of Internal Medicine and Cardiology, Semey Medical University, 071400 Semey, Kazakhstan.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
  • Center for Molecular and Cellular Biology, 121205 Moscow, Russia.
  • Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan.
  • Kazakhstan-Japan Innovative Center, Kazakh National Agrarian Research University, 050010 Almaty, Kazakhstan.

ORCID-Profile: Alma Nurtazina, Maxat Toishimanov, Victoria Shender, Georgij Arapidi

Förderung

  • Ministry of Science and Higher Education of the Republic of Kazakhstan
  • Russian Science Foundation

Zitieren

APA

Nurtazina, A., Koss, V., Voitsekhovskiy, I., Toishimanov, M., Dautov, D., Karibayev, K., Shender, V., & Arapidi, G. (2026). LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome. Journal of Personalized Medicine, 16(8), 425. https://doi.org/10.3390/jpm16080425

Vancouver

Nurtazina A, Koss V, Voitsekhovskiy I, Toishimanov M, Dautov D, Karibayev K, et al. LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome. Journal of Personalized Medicine. 2026;16(8):425. doi:10.3390/jpm16080425

BibTeX
@article{Nurtazina2026,
  author = {Nurtazina, Alma and Koss, Valeriia and Voitsekhovskiy, Ivan and Toishimanov, Maxat and Dautov, Daulet and Karibayev, Kairat and Shender, Victoria and Arapidi, Georgij},
  title = {LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {425},
  doi = {10.3390/jpm16080425}
}
Kostenlos starten →